サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1485211

スマートDDS（ドラッグデリバリーシステム）の世界市場レポート 2024年

Smart Drug Delivery Systems Global Market Report 2024

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
スマートDDS（ドラッグデリバリーシステム）の世界市場レポート 2024年
出版日: 2024年05月21日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

スマートDDS（ドラッグデリバリーシステム）の市場規模は今後数年で急成長が見込まれます。2028年にはCAGR19.7％で259億4,000万米ドルに成長します。予測期間中に予想される成長は、非伝染性疾患の負担増、精密医療への注目の高まり、温度計測の台頭、非侵襲的ドラッグデリバリー法に対する需要の高まり、ヘルスケア支出の継続的増加など、いくつかの要因に起因しています。この期間に予想される主な動向には、小型化・微細加工技術の進歩、材料科学の革新、人工知能（AI）と機械学習（ML）の統合、ナノサイズのドラッグデリバリーシステムの開発、IoTとウェアラブル技術のドラッグデリバリーシステムへの統合などがあります。

慢性疾患の有病率の増加は、スマートDDS（ドラッグデリバリーシステム）市場の成長を牽引する構えです。慢性疾患は、進行が遅く原因が複雑な長期的な健康状態を特徴とし、高齢化、環境の影響、ヘルスケアへのアクセス格差などの要因により増加傾向にあります。スマートDDS（ドラッグデリバリーシステム）は、投薬効果を高め、患者のアドヒアランスを向上させることで、慢性疾患の管理に有望なソリューションを提供します。例えば、国立医学図書館（National Library of Medicine）のデータでは、2050年までに少なくとも1つの慢性疾患を持つ個人の数が大幅に増加すると予測されており、スマートDDS（ドラッグデリバリーシステム）市場を推進する上で慢性疾患の有病率の増加が重要な役割を果たすことが強調されています。

スマートDDS（ドラッグデリバリーシステム）市場の主なプレーヤーは、薬剤投与に革命をもたらす革新的な再利用可能ドラッグデリバリー機器の開発に注力しています。そのひとつがQfinityで、薬剤の皮下自己投与用に設計された再利用可能なドラッグデリバリー機器です。Qfinityは単回使用とは異なり、複数回の注射に利用できるため、廃棄物を減らし、環境面でもメリットがあります。例えば、Jabil Inc.は2022年5月にQfinityを発売しました。この装置は1台当たり100回以上の注射が可能で、様々なプレフィルドカートリッジに対応しています。この装置は、注射1本あたりの二酸化炭素排出量を削減するだけでなく、さまざまな薬剤量や粘度に対応する汎用性も備えています。さらに、コネクテッド・バージョンのQfinity+は、内蔵センサーと電子機器により、患者ケアとコンプライアンスの遠隔監視を可能にし、使いやすさを損なうことなく接続性を確保しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界のスマートDDS（ドラッグデリバリーシステム）市場：促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界のスマートDDS（ドラッグデリバリーシステム）市場の実績：規模と成長, 2018-2023
  • 世界のスマートDDS（ドラッグデリバリーシステム）市場の予測：規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

  • 世界のスマートDDS（ドラッグデリバリーシステム）市場：製品別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 接続型吸入器
  • 接続型オートインジェクター
  • 接続型ペン型注射器
  • 接続型ウェアラブルインジェクター
  • アドオンセンサー
  • その他の製品
  • 世界のスマートDDS（ドラッグデリバリーシステム）市場：治療領域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 代謝障害
  • 神経学的障害
  • 呼吸器疾患
  • ホルモン障害
  • その他の治療領域
  • 世界のスマートDDS（ドラッグデリバリーシステム）市場：ドラッグデリバリーモード別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 注射
  • 吸入
  • 経口
  • 世界のスマートDDS（ドラッグデリバリーシステム）市場：エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 病院
  • クリニック
  • 在宅ケア
  • 外来診療環境
  • その他のエンドユーザー

第7章 地域別・国別分析

  • 世界のスマートDDS（ドラッグデリバリーシステム）市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界のスマートDDS（ドラッグデリバリーシステム）市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • スマートDDS（ドラッグデリバリーシステム）市場：競合情勢
  • スマートDDS（ドラッグデリバリーシステム）市場：企業プロファイル
    • Pfizer Inc
    • Johnson & Johnson
    • Bayer AG
    • Abbott Laboratories
    • Novartis International AG

第31章 その他の大手企業と革新的企業

  • Medtronic plc
  • Eli Lilly and Company
  • Amgen Inc
  • Novo Nordisk
  • Merck Group
  • Becton Dickinson and Company
  • Stryker Corporation
  • Baxter International Inc
  • Boston Scientific Corporation
  • Biogen Inc
  • Vertex Pharmaceuticals Incorporated
  • Phillips-Medisize Corporation
  • ResMed Inc.
  • West Pharmaceutical Services Inc
  • Insulet Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r17438

Smart drug delivery systems encompass advanced technologies aimed at enhancing the efficacy, safety, and targeted delivery of pharmaceutical compounds within the body. These systems utilize diverse approaches to regulate drug release, improve bioavailability, and minimize adverse effects.

The primary products within smart drug delivery systems include connected inhalers, connected autoinjectors, connected pen injectors, connected wearable injectors, add-on sensors, and other related devices. Connected inhalers, for instance, are electronic monitoring systems integrated into inhalers, which track drug usage and may provide feedback on device technique. These systems find applications across various therapeutic areas such as metabolic disorders, neurological disorders, respiratory disorders, hormonal disorders, and more. They can deliver drugs via different modes including injectable, inhalation, and oral routes, and cater to a range of end users including hospitals, clinics, home care settings, ambulatory care facilities, among others.

The smart drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides smart drug delivery systems market statistics, including smart drug delivery systems industry global market size, regional shares, competitors with smart drug delivery systems market share, detailed smart drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the smart drug delivery systems industry. This smart drug delivery systems market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart drug delivery systems market size has grown rapidly in recent years. It will grow from $10.61 billion in 2023 to $12.65 billion in 2024 at a compound annual growth rate (CAGR) of 19.2%. The growth observed during the historic period can be attributed to several factors, including the increasing demand for drug delivery systems, rising patient compliance with treatment regimens, the growing prevalence of chronic diseases, the rise of personalized medicine approaches, and the need for cost-effective healthcare solutions.

The smart drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $25.94 billion in 2028 at a compound annual growth rate (CAGR) of 19.7%. The anticipated growth in the forecast period can be attributed to several factors, including the growing burden of non-communicable diseases, an increased focus on precision medicine, the rise of theragnostics, a growing demand for non-invasive drug delivery methods, and the continual increase in healthcare expenditure. Major trends expected during this period include advancements in miniaturization and microfabrication technologies, innovations in material science, the integration of artificial intelligence (AI) and machine learning (ML), the development of nano-sized drug delivery systems, and the integration of IoT and wearable technology into drug delivery systems.

The increasing prevalence of chronic diseases is poised to drive the growth of the smart drug delivery systems market. Chronic diseases, characterized by long-term health conditions with slow progression and complex causes, are on the rise due to factors such as aging populations, environmental influences, and disparities in healthcare access. Smart drug delivery systems offer a promising solution for managing chronic diseases by enhancing medication effectiveness and improving patient adherence. For example, data from the National Library of Medicine forecasts a substantial increase in the number of individuals with at least one chronic illness by 2050, underscoring the significant role of rising chronic disease prevalence in propelling the smart drug delivery systems market.

Key players in the smart drug delivery systems market are focused on developing innovative reusable drug delivery devices to revolutionize drug administration. One such device is Qfinity, a reusable drug delivery device designed for subcutaneous self-administration of medication. Unlike single-use devices, Qfinity can be utilized for multiple injections, reducing waste and offering environmental benefits. For instance, Jabil Inc. launched Qfinity in May 2022, featuring the capability to handle over 100 injections per device and accommodating various pre-filled cartridges. The device not only reduces the carbon footprint per injection but also offers versatility in handling different drug volumes and viscosities. Additionally, the connected version, Qfinity+, enables remote monitoring of patient care and compliance through built-in sensors and electronics, ensuring connectivity without compromising ease of use.

In October 2023, Novo Nordisk A/S strengthened its position in the smart drug delivery systems market through the acquisition of Biocorp Production SA for $164.5 million. This strategic move aims to augment Novo Nordisk's capabilities in developing innovative connected devices and delivery solutions, exemplified by Mallya, a smart add-on device for pen injectors. Biocorp, a France-based designer and manufacturer of medical devices and drug delivery systems, brings expertise in connected devices that align with Novo Nordisk's focus on advancing drug delivery technologies to enhance patient care and treatment outcomes.

Major companies operating in the smart drug delivery systems market are Pfizer Inc, Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc, Boston Scientific Corporation, Biogen Inc, Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc, Insulet Corporation, Owen Mumford Ltd, Sonceboz, H&T Presspart Manufacturing Ltd, E3D Elcam Drug Delivery Devices, CeQur Corporation

North America was the largest region in the smart drug delivery systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the smart drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart drug delivery systems market consists of revenues earned by entities by providing services such as personalized drug delivery, targeted treatment, diagnostic integration, remote monitoring, and feedback mechanisms. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart drug delivery systems market also includes sales of products including microfluidic devices, transdermal drug delivery patches, electroceutical devices, and remote-controlled drug delivery devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

  • Including: 1) By Product: Connected Inhalers; Connected Autoinjectors; Connected Pen Injectors; Connected Wearable Injectors; Add-On Sensors
  • 2) By Therapeutic Area: Metabolic Disorders; Neurological Disorders; Respiratory Disorders; Hormonal Disorders
  • 3) By Drug Delivery Mode: Injectable; Inhalation; Oral
  • 4) By End-User: Hospitals; Clinics; Home Care; Ambulatory Care Settings
  • Covering: Pfizer Inc.; Johnson & Johnson; Bayer AG; Abbott Laboratories; Novartis International AG

Table of Contents

1. Executive Summary

2. Smart Drug Delivery Systems Market Characteristics

3. Smart Drug Delivery Systems Market Trends And Strategies

4. Smart Drug Delivery Systems Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Smart Drug Delivery Systems Market Size and Growth

  • 5.1. Global Smart Drug Delivery Systems Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Smart Drug Delivery Systems Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Smart Drug Delivery Systems Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Smart Drug Delivery Systems Market Segmentation

  • 6.1. Global Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Connected Inhalers
  • Connected Autoinjectors
  • Connected Pen Injectors
  • Connected Wearable Injectors
  • Add-On Sensors
  • Other Products
  • 6.2. Global Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Metabolic Disorders
  • Neurological Disorders
  • Respiratory Disorders
  • Hormonal Disorders
  • Other Therapeutic Areas
  • 6.3. Global Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Injectable
  • Inhalation
  • Oral
  • 6.4. Global Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Home Care
  • Ambulatory Care Settings
  • Other End-Users

7. Smart Drug Delivery Systems Market Regional And Country Analysis

  • 7.1. Global Smart Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Smart Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Smart Drug Delivery Systems Market

  • 8.1. Asia-Pacific Smart Drug Delivery Systems Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Smart Drug Delivery Systems Market

  • 9.1. China Smart Drug Delivery Systems Market Overview
  • 9.2. China Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Smart Drug Delivery Systems Market

  • 10.1. India Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Smart Drug Delivery Systems Market

  • 11.1. Japan Smart Drug Delivery Systems Market Overview
  • 11.2. Japan Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Smart Drug Delivery Systems Market

  • 12.1. Australia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Smart Drug Delivery Systems Market

  • 13.1. Indonesia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Smart Drug Delivery Systems Market

  • 14.1. South Korea Smart Drug Delivery Systems Market Overview
  • 14.2. South Korea Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Smart Drug Delivery Systems Market

  • 15.1. Western Europe Smart Drug Delivery Systems Market Overview
  • 15.2. Western Europe Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Smart Drug Delivery Systems Market

  • 16.1. UK Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Smart Drug Delivery Systems Market

  • 17.1. Germany Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Smart Drug Delivery Systems Market

  • 18.1. France Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Smart Drug Delivery Systems Market

  • 19.1. Italy Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Smart Drug Delivery Systems Market

  • 20.1. Spain Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Smart Drug Delivery Systems Market

  • 21.1. Eastern Europe Smart Drug Delivery Systems Market Overview
  • 21.2. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Smart Drug Delivery Systems Market

  • 22.1. Russia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Smart Drug Delivery Systems Market

  • 23.1. North America Smart Drug Delivery Systems Market Overview
  • 23.2. North America Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Smart Drug Delivery Systems Market

  • 24.1. USA Smart Drug Delivery Systems Market Overview
  • 24.2. USA Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Smart Drug Delivery Systems Market

  • 25.1. Canada Smart Drug Delivery Systems Market Overview
  • 25.2. Canada Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Smart Drug Delivery Systems Market

  • 26.1. South America Smart Drug Delivery Systems Market Overview
  • 26.2. South America Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Smart Drug Delivery Systems Market

  • 27.1. Brazil Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Smart Drug Delivery Systems Market

  • 28.1. Middle East Smart Drug Delivery Systems Market Overview
  • 28.2. Middle East Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Smart Drug Delivery Systems Market

  • 29.1. Africa Smart Drug Delivery Systems Market Overview
  • 29.2. Africa Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Smart Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 30.1. Smart Drug Delivery Systems Market Competitive Landscape
  • 30.2. Smart Drug Delivery Systems Market Company Profiles
    • 30.2.1. Pfizer Inc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bayer AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis International AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Smart Drug Delivery Systems Market Other Major And Innovative Companies

  • 31.1. Medtronic plc
  • 31.2. Eli Lilly and Company
  • 31.3. Amgen Inc
  • 31.4. Novo Nordisk
  • 31.5. Merck Group
  • 31.6. Becton Dickinson and Company
  • 31.7. Stryker Corporation
  • 31.8. Baxter International Inc
  • 31.9. Boston Scientific Corporation
  • 31.10. Biogen Inc
  • 31.11. Vertex Pharmaceuticals Incorporated
  • 31.12. Phillips-Medisize Corporation
  • 31.13. ResMed Inc.
  • 31.14. West Pharmaceutical Services Inc
  • 31.15. Insulet Corporation

32. Global Smart Drug Delivery Systems Market Competitive Benchmarking

33. Global Smart Drug Delivery Systems Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Smart Drug Delivery Systems Market

35. Smart Drug Delivery Systems Market Future Outlook and Potential Analysis

  • 35.1 Smart Drug Delivery Systems Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Smart Drug Delivery Systems Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Smart Drug Delivery Systems Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer